3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2H-indol-2-one,
BHPI,
56632-39-4,
MLS000573319,
3,3-bis(4-hydroxyphenyl)-7-methyl-1H-indol-2-one,
SMR000194821,
3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2H-indol-2-one,
AC1MYQB4,
Cambridge id 6373538,
CHEMBL394883,
SCHEMBL5478375,
BDBM61491,
cid_3860640,
CTK1F4188,
AOB5365,
DTXSID00397487,
FABLAHMQSQFDHR-UHFFFAOYSA-N,
REGID_for_CID_3860640,
HMS2153B10,
DNDI1417434,
KS-00001D1Q,
ZINC4302867,
CCG-21503,
AKOS000350526,
CS-4205,
MCULE-6280329543,
NCGC00408892-01,
AS-16880,
HY-12825,
3,3-bis(4-hydroxyphenyl)-7-methyl-oxindole,
EU-0079779,
MLS-0096071.0001,
3,3-bis(4-hydroxyphenyl)-7-methylindolin-2-one,
AB00105948-01,
SR-01000502745,
3,3-bis-(4-hydroxy-phenyl)-7-methyl-2-indolinone,
3,3-bis-(4-hydroxyphenyl)-7-methyl-2 -indolinone,
SR-01000502745-1,
1,3-Dihydro-3,3-bis(4-hydroxyphenyl)-7-methyl-2H-indol-2-one,
2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxyphenyl)-7-methyl-,
2H-INDOL-2-ONE,1,3-DIHYDRO-3,3-BIS(4-HYDROXYPHENYL)-7-METHYL-,
CID3860640,